
|Articles|July 14, 2022
Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in Kids
Author(s)Miranda Hester
Paller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
The SkinCARE Questionnaire: Assessing the Psychological Dimensions of Skin Health Beyond Disease
5


















